Results 131 to 140 of about 17,302 (216)

Long-term outcomes of azacitidine, venetoclax, and gilteritinib in newly diagnosed FLT3-mutated AML. [PDF]

open access: yesBlood Adv
Short NJ   +21 more
europepmc   +1 more source

Fatal Bone marrow necrosis following azacitidine and granulocyte colony-stimulating factor administration in a patient with high-risk myelodysplastic syndrome [PDF]

open access: yes
論文(Article)Azacitidine, which has the capacity to induce DNA hypomethylation in vitro, is currently available for treatment of myelodysplastic syndrome (MDS).
加藤, 丈夫   +4 more
core  

Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II study. [PDF]

open access: yesExp Hematol Oncol
Ma L   +18 more
europepmc   +1 more source

Correction: Survival of myelodysplastic syndrome patients after azacitidine therapy. [PDF]

open access: yesBMC Cancer
Thammagul K   +5 more
europepmc   +1 more source

A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma. [PDF]

open access: yesHematol Oncol
Saeed H   +15 more
europepmc   +1 more source

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus. [PDF]

open access: yesCurr Oncol
Schuh AC   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy